Here's What Analysts Are Saying About AtaiBeckley Inc. (ATAI)

AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best strong buy penny stocks to invest in. AtaiBeckley Inc. (NASDAQ:ATAI) has received several rating updates since the beginning of the year. H.C. Wainwright expressed bullish sentiments for AtaiBeckley Inc. (NASDAQ:ATAI) on January 28, maintaining a Buy rating on the stock with a $15 price target. In another development, AtaiBeckley Inc. (NASDAQ:ATAI) was initiated with a Buy rating at Guggenheim on January 20, with the firm setting an $11 price target.

Guggenheim based the rating on the company’s position as “a differentiated leader in next-generation psychiatry”, stating that the recent merger with Beckley Psytech allows complete ownership of BPL-003, the lead asset, which has exhibited “compelling” Phase IIIb efficacy and durability in treatment-resistant depression. The firm believes that BPL-003 is “uniquely positioned for rapid clinical adoption and commercial scale.”

AtaiBeckley Inc. (NASDAQ:ATAI) also received a rating update from JonesTrading on January 16, which reaffirmed a Buy rating on the stock and set a price target of $16, basing it on the company’s market opportunity and advancing clinical pipeline. It told investors that the company is positioned for a data-rich 2026, with pivotal Phase II results anticipated from all three of the company’s clinical programs in 2026. According to the firm, this holds the potential to considerably de-risk the story.

JonesTrading also considers the lead compounds BPL-003 and VLS-01 to be well-suited for treatment-resistant depression, primarily because of their short duration of action, supporting a clinic-based model similar to the commercial framework by esketamine.

Headquartered in Germany, AtaiBeckley Inc. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company focused on treating mental health disorders.

While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.